Sutimlimab Biosimilar - Research Grade [ICH5012]

Catalogue Number: ICH5012-ICB

Manufacturer:	IchorBio
Type:	Recombinant Monoclonal
Shipping Condition:	Blue Ice
Unit(s):	10 mg, 20 mg, 5 mg, 50 mg, 1 mg, 100 mg
Host name:
Clone:
Isotype:	IgG4
Immunogen:
Application:	FA

Overview
Datasheets

Description

Description: RUO sutimlimab biosimilar is a humanized monoclonal antibody that is designed to selectively target and inhibit C1s in the classical complement pathway, which is part of the innate immune system. By blocking C1s, sutimlimab inhibits the activation of the classical complement pathway with the goal of halting C1-activated hemolysis in cold agglutinin disease to prevent the abnormal destruction of healthy red blood cells. By selectively inhibiting the classical pathway upstream at C1s, sutimlimab does not inhibit the lectin and alternative complement pathways.

Additional Text

Gene Name

C1S

Concentration

5 mg/ml

Gene ID

716

Uniprot ID

P09871

Purification

Protein A/G Purified

Antibody Clonality

Recombinant Monoclonal

Application Notes

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Storage Note

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

ICH5012 Datasheet

Price

£1,118.00

-

Quantity
Unit Size

Find out about delivery